Malvinder Mohan Singh has stepped down as chairman, ceo and managing director of Indian pharmaceutical company Ranbaxy. Atul Sobti, currently chief operating officer, has been appointed ceo and managing director. Tsutomu Un, currently a non-executive director of the board, has been appointed chairman. Ranbaxy is a subsidiary of Japanese pharmaceutical company Daiichi-Sankyo.
Ranbaxy.(Movers & shakers)(appointments by Ranbaxy Pharmaceuticals Inc. )(Brief article)
COPYRIGHT 2009 Society of Chemical
Industry Reproduced with permission of the copyright holder. Further reproduction or distribution is prohibited without permission.
Copyright 2009 Gale, Cengage Learning. All rights reserved. Gale Group is a Thomson Corporation Company. NOTE: All illustrations and photos have been removed from this article. |
|||




Mobile Edition
Print
Get the Mag
Weekly Updates